Evidence map›Paper›PMID 40968390›Full record

ArticleInfectious diseases (London, England)2026

Epidemiology and antimicrobial resistance of

Felicita Medalla, Hazel J Shah, Preethi Sundararaman, Jessica Chen, Zachary Ellison, Sarah Verlander, Sean Buuck, Samir Hanna, Rebecca Hoelzl, Tamara Rissman and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious diseases (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Felicita MedallaCenters for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-9632-6117
Hazel J ShahCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Preethi SundararamanCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Jessica ChenCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Zachary EllisonApplied Science, Research, and Technology, Inc., Smyrna, Georgia, USA.
Sarah VerlanderCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Sean BuuckMinnesota Department of Health, Saint Paul, Minnesota, USA.
Samir HannaTennessee Department of Health, Nashville, Tennessee, USA.
Rebecca HoelzlNew York State Department of Health, Albany, New York, USA.
Tamara RissmanConnecticut Emerging Infections Program, New Haven, Connecticut, USA.
Rosalie TrevejoOregon Health Authority Public Health Division, Portland, Oregon, USA.
Carey DevineCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Meseret G BirhaneCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Jared L ReynoldsCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Hayat CaidiCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Jason FolsterCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Beth TolarCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Daniel C PayneCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Robert M HoekstraCenters for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-0340-8015
Louise Francois WatkinsCenters for Disease Control and Prevention, Atlanta, Georgia, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

background

objectiveThe study aimed to describe the epidemiology and antimicrobial resistance of human

methodsThe study used data from five CDC surveillance systems, with combined years from 1979 through 2022. Negative binomial and logistic regression models were used in the multivariable analyses of surveillance data.

resultsIn 10 active surveillance sites, the mean annual incidence of human

conclusionThe increase in

Indexed as

Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialSalmonella entericaSalmonella InfectionsAdolescentAdultAgedAnimalsChickensChildChild, PreschoolFemaleHumansIncidenceInfantMaleAnti-Bacterial Agentsantimicrobial resistanceincidenceInfantismultidrug resistancepESIREPJFX01Salmonella

Identifiers

PMID40968390
PMCPMC12961576

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.